PCOS to PMOS: A Shift Toward a More Complete Understanding

A recent American Journal of Managed Care article highlights growing discussion around renaming Polycystic Ovary Syndrome (PCOS) to Polycystic Metabolic Syndrome (PMOS). The proposed change reflects a more comprehensive view of the condition, recognizing its metabolic and endocrine components alongside its reproductive effects.

A “Polyendocrine” Condition Beyond the Ovaries

The article features insights from HRC Fertility’s Dr. Mickey Coffler, who describes PMOS as a “polyendocrine” condition. He explains that infertility in these patients is not driven solely by ovarian dysfunction, but by multiple interacting hormonal systems, including insulin and neuroendocrine hormones.

He notes that this interconnected hormonal disruption means PMOS cannot be understood through a single-organ lens, but rather as a broader imbalance across the endocrine system that impacts reproductive health.

Treating the Underlying Drivers

Dr. Coffler emphasizes that this perspective opens the door to more targeted treatment approaches that address underlying metabolic and endocrine dysfunction. Instead of focusing only on ovarian symptoms, care can be directed toward upstream factors like insulin resistance that contribute to hormonal imbalance.

By addressing these root causes, clinicians may be better able to restore spontaneous ovulation and improve pregnancy outcomes affected by this complex hormonal interplay.

Advancing a More Integrated Approach to Care

As research continues to evolve, the shift from PCOS to PMOS reflects a move toward more comprehensive, whole-body reproductive care. Understanding both the metabolic and endocrine components of the condition allows for more individualized treatment strategies.

At HRC Fertility, physicians like Dr. Coffler continue to contribute to this evolving conversation, helping translate emerging research into more informed, patient-centered care.

You can read the full article PCOS Renamed PMOS